Trial Profile
Clinical Trials Insight: 700042713
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 23 Mar 2009
Price :
$35
*
At a glance
- Drugs Vadimezan (Primary) ; Taxanes
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Novartis
- 23 Mar 2009 New trial record.